This Oppenheimer Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Veradermics, Incorporated
Mobia Medical, Inc.
Odyssey Therapeutics, Inc.

Veradermics, Incorporated

MANE

0.00

Mobia Medical, Inc.

MOBI

0.00

Odyssey Therapeutics, Inc.

ODTX

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Oppenheimer analyst Jeff Jones initiated coverage on Odyssey Therapeutics Inc (NASDAQ:ODTX) with an Outperform rating and announced a price target of $40. Odyssey Therapeutics shares closed at $16.96 on Tuesday. See how other analysts view this stock.
  • BofA Securities analyst Travis Steed initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $16. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.
  • BTIG analyst Ryan Zimmerman initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $19. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.
  • Needham analyst Serge Belanger initiated coverage on Veradermics Inc (NASDAQ:MANE) with a Buy rating and announced a price target of $136. Veradermics shares closed at $101.51 on Tuesday. See how other analysts view this stock.
  • Goldman Sachs analyst David Roman initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $31. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.

Considering buying MOBI stock? Here’s what analysts think:

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.